CN1054128C - 4－烷氧基－2,6－二叔丁基苯酚衍生物 - Google Patents

4－烷氧基－2,6－二叔丁基苯酚衍生物 Download PDF

Info

Publication number
CN1054128C
CN1054128C CN93120400A CN93120400A CN1054128C CN 1054128 C CN1054128 C CN 1054128C CN 93120400 A CN93120400 A CN 93120400A CN 93120400 A CN93120400 A CN 93120400A CN 1054128 C CN1054128 C CN 1054128C
Authority
CN
China
Prior art keywords
compound
butyl
methyl
formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN93120400A
Other languages
English (en)
Chinese (zh)
Other versions
CN1112115A (zh
Inventor
田村邦雄
加藤好章
吉田光孝
进士修
大场康博
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of CN1112115A publication Critical patent/CN1112115A/zh
Application granted granted Critical
Publication of CN1054128C publication Critical patent/CN1054128C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN93120400A 1992-10-16 1993-10-16 4－烷氧基－2,6－二叔丁基苯酚衍生物 Expired - Fee Related CN1054128C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP321101/1992 1992-10-16
JP321101/92 1992-10-16
JP32110192 1992-10-16

Publications (2)

Publication Number Publication Date
CN1112115A CN1112115A (zh) 1995-11-22
CN1054128C true CN1054128C (zh) 2000-07-05

Family

ID=18128834

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93120400A Expired - Fee Related CN1054128C (zh) 1992-10-16 1993-10-16 4－烷氧基－2,6－二叔丁基苯酚衍生物

Country Status (14)

Country Link
US (3) US5574178A (enExample)
EP (1) EP0665208B1 (enExample)
KR (1) KR100247213B1 (enExample)
CN (1) CN1054128C (enExample)
AT (1) ATE175658T1 (enExample)
AU (1) AU6241894A (enExample)
CA (1) CA2147263C (enExample)
DE (1) DE69323090T2 (enExample)
DK (1) DK0665208T3 (enExample)
ES (1) ES2128440T3 (enExample)
GR (1) GR3029810T3 (enExample)
SG (1) SG49937A1 (enExample)
TW (1) TW393475B (enExample)
WO (1) WO1994008930A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995029906A1 (en) * 1994-04-28 1995-11-09 Meiji Milk Products Co., Ltd. Benzofuran derivative and use thereof
US5674876A (en) * 1995-01-20 1997-10-07 Research Development Foundation ρ-heteroatom-substituted phenols and uses thereof
EP0749972A1 (en) * 1995-06-21 1996-12-27 Merrell Pharmaceuticals Inc. A process for preparing 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanone derivatives
TW565558B (en) * 1995-11-09 2003-12-11 Chugai Pharmaceutical Co Ltd Intimal thickening inhibitory agent
KR100383835B1 (ko) * 1996-06-26 2003-08-27 쥬가이 세이야쿠 가부시키가이샤 신장질환치료제및장기보존제
US6114572A (en) * 1996-11-20 2000-09-05 Hoechst Marion Roussel, Inc. Substituted phenols and thiophenols useful as antioxidant agents
NZ335440A (en) * 1996-11-20 2001-07-27 Aventis Pharma Inc Control of vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) mediated effects to treat chronic inflammatory disorders like atheriosclerosis
US5679820A (en) * 1996-12-16 1997-10-21 General Electric Company Silylated ultraviolet light absorbers having resistance to humidity
WO1998050025A1 (en) * 1997-05-08 1998-11-12 Chugai Seiyaku Kabushiki Kaisha Preventives/remedies for arteriosclerosis
TW472051B (en) * 1997-05-23 2002-01-11 Chugai Pharmaceutical Co Ltd 2,3-dihydrobenzofuran derivatives
EP1172104A4 (en) * 1999-02-23 2002-11-27 Chugai Pharmaceutical Co Ltd PREPARATIONS FROM SOFT POCKET CAPSULES CONTAINING DIHYDROBENZOFURANE DERIVATIVES
DE19941595A1 (de) * 1999-09-01 2001-03-08 Basf Ag Verwendung von anellierten Benzolderivaten als Antioxidans oder Radikalfänger in kosmetischen Zubereitungen
EP1304328A4 (en) * 2000-07-19 2004-06-16 Chugai Pharmaceutical Co Ltd METHOD FOR PRODUCING A BENZOFURANE DERIVATIVE
US20040242678A1 (en) * 2001-08-31 2004-12-02 Shinji Yokoyama Apolipo protein e secretion promoters
US20050159476A1 (en) * 2002-03-29 2005-07-21 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for preventing or treating respiratory disease
US6882245B2 (en) * 2002-06-05 2005-04-19 Rf Stream Corporation Frequency discrete LC filter bank
US20070066681A1 (en) * 2003-09-26 2007-03-22 Chugai Seiyaku Kaushiki Kaisha Pharmaceutical composition for treating fatty liver or hepatic disease
CN110940747B (zh) * 2019-12-03 2022-06-28 酒泉市食品检验检测中心 一种马铃薯及其制品中α-茄碱和α-卡茄碱的测定方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857516A (en) * 1986-12-27 1989-08-15 Takeda Chemical Industries, Ltd. Coumaran derivatives and their pharmaceutical use
JPH02121975A (ja) * 1988-10-28 1990-05-09 Eisai Co Ltd ２，３−ジヒドロベンゾフラン誘導体
US4978761A (en) * 1988-06-10 1990-12-18 Takeda Chemical Industries, Ltd. 5-hydroxy-2-substituted-2,4,6,7-tetramethyl-2,3-dihydrobenzofurans
WO1992016485A1 (de) * 1991-03-23 1992-10-01 Boehringer Mannheim Gmbh Neue phenolether, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085871B2 (ja) * 1986-12-27 1996-01-24 武田薬品工業株式会社 クマラン誘導体およびその製造法
JP2855341B2 (ja) * 1988-06-10 1999-02-10 武田薬品工業株式会社 新規２―置換クマラン誘導体
IT1229482B (it) * 1988-08-01 1991-09-03 Foscama Biomed Chim Farma Acidi (rs) 2 (2,3 diidro 5 idrossi 4,6,7 trimetilbenzofuranil) acetico e 2 (2,3 diidro 5 acilossi 4,6,7 trimetilbenzofuranil) acetici e loro esteri, utili come farmaci mucoregolatori ed antiischemici.
US4966907A (en) * 1988-08-12 1990-10-30 Merck & Co., Inc. 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis
US5091533A (en) * 1990-03-12 1992-02-25 Merck Frosst Canada, Inc. 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors
JPH04300878A (ja) * 1991-03-28 1992-10-23 Fujirebio Inc ベンゼンジオール誘導体
CA2124086A1 (en) * 1991-11-22 1993-05-27 Ronald H. Lane Tocotrienols and tocotrienol-like compounds and methods for their use
JP3150740B2 (ja) * 1991-12-26 2001-03-26 エーザイ株式会社 ジヒドロベンゾフラン誘導体
DE69314022T2 (de) * 1992-04-06 1998-02-12 Merrell Pharma Inc Derivate von 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857516A (en) * 1986-12-27 1989-08-15 Takeda Chemical Industries, Ltd. Coumaran derivatives and their pharmaceutical use
US4978761A (en) * 1988-06-10 1990-12-18 Takeda Chemical Industries, Ltd. 5-hydroxy-2-substituted-2,4,6,7-tetramethyl-2,3-dihydrobenzofurans
JPH02121975A (ja) * 1988-10-28 1990-05-09 Eisai Co Ltd ２，３−ジヒドロベンゾフラン誘導体
WO1992016485A1 (de) * 1991-03-23 1992-10-01 Boehringer Mannheim Gmbh Neue phenolether, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten

Also Published As

Publication number Publication date
ATE175658T1 (de) 1999-01-15
KR950703503A (ko) 1995-09-20
KR100247213B1 (ko) 2000-03-15
WO1994008930A1 (fr) 1994-04-28
CA2147263C (en) 2004-12-21
GR3029810T3 (en) 1999-06-30
SG49937A1 (en) 1998-06-15
EP0665208A1 (en) 1995-08-02
US5606089A (en) 1997-02-25
US5574178A (en) 1996-11-12
ES2128440T3 (es) 1999-05-16
AU6241894A (en) 1994-05-09
DE69323090D1 (de) 1999-02-25
DK0665208T3 (da) 1999-08-30
DE69323090T2 (de) 2000-01-27
CN1112115A (zh) 1995-11-22
EP0665208B1 (en) 1999-01-13
TW393475B (en) 2000-06-11
EP0665208A4 (enExample) 1995-08-23
US5663373A (en) 1997-09-02
CA2147263A1 (en) 1994-04-28

Similar Documents

Publication Publication Date Title
CN1054128C (zh) 4－烷氧基－2,6－二叔丁基苯酚衍生物
CN1273467C (zh) β－内酰胺化合物、这些化合物的制备方法以及含有这些化合物的降血清胆固醇药
CN1066441C (zh) 异唑基苯基磺酰胺的衍生物及其在制备内皮缩血管肽拮抗药中的应用
CN1079224A (zh) 抗菌素化合物
CN1051308C (zh) 噁唑烷－2－酮衍生物和含有这些物质的药物
CN1032203C (zh) 制备取代2-吡啶酮和吡啶-2-硫酮的方法
CN1028529C (zh) 内亚苯基氧杂双环庚基取代的前列腺素类似物的制法
CN1161035A (zh) 降血脂1，4-苯并氮杂䓬-1，1-二氧化物
CN1082040A (zh) 吲哚类
CN1193966A (zh) 芳族化合物和含有它们的药物组合物
CN1077954A (zh) 新的苯并吡喃衍生物
CN1053062A (zh) 新的维生素e衍生物及其制备方法
CN1159303C (zh) 单环β-内酰胺类抗生素衍生物的中间体的制备方法
CN1033639C (zh) 含有醌基的噻唑烷化合物的制备方法
CN1068821A (zh) 苯并二氢吡喃衍生物
CN1090282A (zh) 苯稠合羟基取代的环烷基和杂环化合物的磺酰胺衍生物
CN1098102A (zh) 7-氧杂二环庚烷羧酸前列腺素同系物中间体及其制法
CN1653071A (zh) 对耐药菌有效的10－(3－环丙基氨基甲基－1－吡咯烷基)吡啶并苯并噁嗪羧酸衍生物
CN1067044C (zh) 新的三环衍生物和它们的制备方法
CN1013440B (zh) 非天然神经酰胺相关化合物的制备方法
CN1048041A (zh) 二苯并[1，5]二氧杂环辛烷-5-酮衍生物及其制备方法和药物用途
CN1112924A (zh) 新的噻嗪或硫代吗啉衍生物
CN1301244C (zh) 生产(r)－3－羟基－3－(2－苯基乙基)己酸及其中间体的方法
CN1753898A (zh) 六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法
CN1028754C (zh) 喹啉衍生物的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee